Evolus (EOLS) Revenue Growth (3y) (2022 - 2026)
Evolus (EOLS) Revenue Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.84% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 4.19% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 15.52% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.49% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.66% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 2.94% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.41% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.17% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 7.85% |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | 20.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.58% |
| Dec 31, 2025 | 27.42% |
| Sep 30, 2025 | 26.71% |
| Jun 30, 2025 | 23.14% |
| Mar 31, 2025 | 26.43% |
| Dec 31, 2024 | 31.58% |
| Sep 30, 2024 | 31.81% |
| Jun 30, 2024 | 36.87% |
| Mar 31, 2024 | 69.24% |
| Dec 31, 2023 | 43.65% |
| Sep 30, 2023 | 41.48% |
| Jun 30, 2023 | 84.90% |
| Mar 31, 2023 | 58.41% |
| Dec 31, 2022 | 30.93% |
| Sep 30, 2022 | 37.06% |
| Jun 30, 2022 | 152.41% |